Skip to main content
. 2020 Feb 11;4(3):586–598. doi: 10.1182/bloodadvances.2019000359

Table 1.

SINE compounds and venetoclax display differential growth inhibition of malignant myeloid cell lines

Cell line Average GI50 at 72 h, nM
Selinexor Eltanexor Venetoclax
MOLM-13 52 32 25
MV-4-11 57 22 52
K-562 241 104 >5000
MOLM-16 165 59 >5000
U-937 444 131 >5000
NB4 571 264 >1000

Values are averaged from 3 independent experiments.